Loading chat...
ND HB1452
Bill
Status
1/16/2025
Primary Sponsor
Jon Nelson
Click for details
AI Summary
-
Requires North Dakota's public employee health insurance to cover at least two FDA-approved antiobesity medications indicated for chronic weight management in patients with obesity
-
Prohibits coverage criteria more restrictive than FDA-approved indications, though standard cost-sharing (deductibles, copays, coinsurance) may apply consistent with other prescription drug coverage
-
Mandates insurers provide written notice to policyholders about the antiobesity medication coverage in annual mailings or other correspondence
-
Applies to health benefits coverage beginning after June 30, 2025, with the entire Act expiring June 30, 2027 (two-year pilot period)
-
Requires the Public Employees Retirement System to submit a bill to the 70th Legislative Assembly with a report on utilization, costs, and recommendation on whether to extend coverage to all group and individual health insurance policies
Legislative Description
Minimum standards for coverage of antiobesity medication; to provide for a report to the legislative assembly; to provide for application; and to provide an expiration date.
Last Action
Second reading, failed to pass, yeas 11 nays 82
2/12/2025